ATE302746T1 - Amorphe salpetersäureester und deren pharmazeutische zusammensetzungen - Google Patents

Amorphe salpetersäureester und deren pharmazeutische zusammensetzungen

Info

Publication number
ATE302746T1
ATE302746T1 AT00949202T AT00949202T ATE302746T1 AT E302746 T1 ATE302746 T1 AT E302746T1 AT 00949202 T AT00949202 T AT 00949202T AT 00949202 T AT00949202 T AT 00949202T AT E302746 T1 ATE302746 T1 AT E302746T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
nitric esters
amorphous
amorphous nitric
esters
Prior art date
Application number
AT00949202T
Other languages
English (en)
Inventor
Francesca Benedini
Patrizia Antognazza
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Application granted granted Critical
Publication of ATE302746T1 publication Critical patent/ATE302746T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C203/00—Esters of nitric or nitrous acid
    • C07C203/02—Esters of nitric acid
    • C07C203/04—Esters of nitric acid having nitrate groups bound to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT00949202T 1999-06-24 2000-06-21 Amorphe salpetersäureester und deren pharmazeutische zusammensetzungen ATE302746T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001402A IT1312115B1 (it) 1999-06-24 1999-06-24 Composti amorfi e relative composizioni farmaceutiche
PCT/EP2000/005723 WO2001000563A1 (en) 1999-06-24 2000-06-21 Amorphous nitric esters and their pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE302746T1 true ATE302746T1 (de) 2005-09-15

Family

ID=11383219

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00949202T ATE302746T1 (de) 1999-06-24 2000-06-21 Amorphe salpetersäureester und deren pharmazeutische zusammensetzungen

Country Status (23)

Country Link
US (1) US6753442B1 (de)
EP (1) EP1187803B1 (de)
JP (1) JP2003503380A (de)
KR (1) KR100672001B1 (de)
CN (1) CN1187312C (de)
AT (1) ATE302746T1 (de)
AU (1) AU781479B2 (de)
BR (1) BR0011831A (de)
CA (1) CA2377132A1 (de)
DE (1) DE60022188T2 (de)
DK (1) DK1187803T3 (de)
ES (1) ES2246878T3 (de)
HU (1) HUP0201721A3 (de)
IL (1) IL146789A0 (de)
IT (1) IT1312115B1 (de)
MX (1) MXPA01013273A (de)
NO (1) NO321523B1 (de)
NZ (1) NZ515757A (de)
PL (1) PL195557B1 (de)
RU (1) RU2248963C2 (de)
TR (1) TR200103624T2 (de)
WO (1) WO2001000563A1 (de)
ZA (1) ZA200109862B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523958A (ja) 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−２の阻害剤、組成物ならびに使用法
IT1319202B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
CA2432642A1 (en) 2000-12-21 2002-08-08 Subhash P. Khanapure Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
EP1219306A1 (de) 2000-12-29 2002-07-03 Nicox S.A. Zyklodextrin und NO-abgebende Arzneimittlen enthaltende Zusammensetzungen
US7220749B2 (en) 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
JP2005539089A (ja) 2002-07-03 2005-12-22 ニトロメッド インコーポレーティッド ニトロソ化非ステロイド性抗炎症化合物、組成物および使用方法
CA2493156A1 (en) 2002-07-29 2004-02-05 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
NZ544331A (en) 2003-07-22 2010-03-26 Arena Pharm Inc Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
ES2421237T7 (es) 2007-08-15 2013-09-30 Arena Pharmaceuticals, Inc. Derivados de imidazo[1,2-a]piridin como moduladores del receptor serotoninérgico 5ht2a en el tratamiento de trastornos relacionados con el mismo
BRPI0818575A2 (pt) * 2007-10-17 2014-10-07 Todd F Ovokaitys Processo para a modificação do estado sólido de um composto e composições co-amorfas produzidas com o mesmo
EA027333B1 (ru) * 2007-10-17 2017-07-31 Тодд Ф. Овокайтис Стабильный при комнатной температуре некристаллический аспирин
ES2324007A1 (es) * 2007-10-25 2009-07-28 Ferrer Internacional, S.A. Una forma amorfa de un compuesto antiinflamatorio.
WO2009123714A2 (en) 2008-04-02 2009-10-08 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
TR201805216T4 (en) 2008-10-28 2018-06-21 Arena Pharm Inc COMPOSITIONS OF A USEFUL 5-HT2A SEROTONINE RECEPTOR MODULATOR FOR THE TREATMENT OF RELATED DISORDERS
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
EP2344592B1 (de) 2008-11-04 2014-12-17 DSM IP Assets B.V. Strahlungshärtbare d 1413 ht-beschichtungen für optische fasern
US10202598B2 (en) 2014-05-30 2019-02-12 Todd Frank Ovokaitys Methods and systems for generation, use, and delivery of activated stem cells
US10040728B2 (en) 2014-06-06 2018-08-07 Todd Frank Ovokaitys Methods and compositions for increasing the bioactivity of nutrients
US10384985B2 (en) 2014-06-06 2019-08-20 B.K. Consultants, Inc. Methods and compositions for increasing the yield of, and beneficial chemical composition of, certain plants
JP2018516992A (ja) 2015-06-12 2018-06-28 アクソファント サイエンシーズ ゲーエムベーハーＡｘｏｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
CN108472285A (zh) 2015-07-15 2018-08-31 阿速万科学有限责任公司 用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物
CA3201604A1 (en) 2020-12-08 2022-06-16 Todd Frank OVOKAITYS Methods and systems for increased production of stem cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243367B (it) * 1990-07-26 1994-06-10 Italfarmaco Spa Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
IT1256345B (it) * 1992-08-20 1995-12-01 Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
IT1256450B (it) 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
RU2145595C1 (ru) * 1994-05-10 2000-02-20 Никокс С.А. Нитроксисоединения и фармацевтическая композиция на их основе, имеющие противовоспалительную, анальгетическую и антитромбоцитарную активности
IT1276071B1 (it) * 1995-10-31 1997-10-24 Nicox Ltd Compositi ad attivita' anti-infiammatoria
KR19990001564A (ko) * 1997-06-16 1999-01-15 유충식 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
IT1307928B1 (it) 1999-01-26 2001-11-29 Nicox Sa Metodo di sintesi di nitrossimetilfenil esteri di derivatidell'aspirina.

Also Published As

Publication number Publication date
NO20016232L (no) 2001-12-19
DE60022188T2 (de) 2006-06-08
AU6264400A (en) 2001-01-31
ES2246878T3 (es) 2006-03-01
KR20020008220A (ko) 2002-01-29
TR200103624T2 (tr) 2002-04-22
KR100672001B1 (ko) 2007-01-19
PL352529A1 (en) 2003-08-25
US6753442B1 (en) 2004-06-22
CN1356975A (zh) 2002-07-03
JP2003503380A (ja) 2003-01-28
ITMI991402A1 (it) 2000-12-24
PL195557B1 (pl) 2007-10-31
HUP0201721A3 (en) 2003-08-28
CA2377132A1 (en) 2001-01-04
EP1187803A1 (de) 2002-03-20
IT1312115B1 (it) 2002-04-04
NZ515757A (en) 2004-02-27
ITMI991402A0 (it) 1999-06-24
RU2248963C2 (ru) 2005-03-27
NO321523B1 (no) 2006-05-15
IL146789A0 (en) 2002-07-25
CN1187312C (zh) 2005-02-02
NO20016232D0 (no) 2001-12-19
WO2001000563A1 (en) 2001-01-04
ZA200109862B (en) 2003-05-28
BR0011831A (pt) 2002-03-19
DE60022188D1 (de) 2005-09-29
MXPA01013273A (es) 2003-07-14
AU781479B2 (en) 2005-05-26
EP1187803B1 (de) 2005-08-24
HUP0201721A2 (en) 2002-10-28
DK1187803T3 (da) 2005-11-28

Similar Documents

Publication Publication Date Title
DE60022188D1 (de) Amorphe salpetersäureester und deren pharmazeutische zusammensetzungen
ATE312613T1 (de) Niedrig dosierte entecavir formulierung und deren verwendung
DE69907977D1 (de) Pyrrolobenzodiazepine
ATE449079T1 (de) Pharmazeutische zusammensetzungen beinhaltend kristallsalze von 7-ä4-(4-fluorophenyl)-6- isopropyl-2-
IL163552A (en) Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
DE60133665D1 (de) Zusammensetzungen enthaltend verzweigte primäre alkohole und deren derivate
BR0107869A (pt) Composições farmacêuticas eletrogiradas
CY1108522T1 (el) Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της
ATE283695T1 (de) Verwendungen und zusammenstellungen von nitratestern als sedativa
ATE288766T1 (de) Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung
ATE429224T1 (de) Arzneizubereitungen enthaltend mindestens einen hiv preoteaseinhibitor
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
EP1221926A4 (de) Pharmazeutische zusammensetzungen mit schlecht löslichen arzneimittelwirkstoffen
SE0003476D0 (sv) Compounds
HUP0303673A3 (en) Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient
DE60024476D1 (de) Pedikulizide und veterinärmedizinische zusammensetzungen
ATE228839T1 (de) Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen
ATE301463T1 (de) Pharmazeutische zusammensetzungen enthaltend 17alpha-furanylester von 17beta-carbothioat androstanderivaten und einen muskarinrezeptorantagonist
ATE290543T1 (de) Pharmazeutische zusammensetzungen mit oligosacchariden und deren herstellung
DE69813263T2 (de) Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte
ATE332140T1 (de) Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen
ATE350064T1 (de) Pharmazeutische zusammensetzungen von rapamycines
IL169163A0 (en) Optically active dihydropyridine derivative and pharmaceutical compositions containing the same
DE60106619D1 (de) Pharmazeutische zusammensetzungen enthaltend tobramycin und xanthangummi
ITMI20001741A0 (it) Composizioni farmaceutiche comprendenti agenti antiinfiammatori e loro usi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1187803

Country of ref document: EP

REN Ceased due to non-payment of the annual fee